Bringing the fundamentals into focus…
Back to DiaMedica Therapeutics Inc.
How DiaMedica Therapeutics Inc. stacks up
DMAC · against 467 other Healthcare companies of similar size
Overall
33/ 100
Near the bottom of its peers.
Ranked #359 of 468 · scores higher than 21% of peers
Bars: peers in each 10-point band of the overall score85 peers with an overall score of 30–39, including DMAC · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around DMAC| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 595M USD | 97 | 96 | 98 | 99 | 0 / 2 | |
| 2 | 609M USD | 91 | 95 | 99 | 99 | 0 / 2 | |
| 3 | 2.9B HKD (≈$365M) | 84 | 99 | 63 | 86 | 0 / 2 | |
| 4 | 7.5B CNY (≈$1.1B) | 82 | 72 | 64 | 96 | 0 / 2 | |
| 5 | 433M USD | 81 | 96 | 99 | 99 | 2 / 2 | |
| 359 | 838M USD | 33 | 59 | 32 | 32 | 2 / 2 | |
| 359 | 841M USD | 33 | 8 | — | 3 | 0 / 2 | |
| 359 | 389M USD | 33 | 33 | 0 | 5 | 0 / 2 | |
| 359 | 472M USD | 33 | 29 | 59 | 34 | 2 / 2 | |
| 359 | 539M USD | 33 | 8 | — | 11 | 0 / 2 | |
| 359 | 966M USD | 33 | 64 | 19 | 39 | 2 / 2 | |
| 359 | 885M USD | 33 | 8 | 99 | 8 | 2 / 2 | |
| 370 | 6.3B CNY (≈$878M) | 32 | 0 | 9 | 26 | 0 / 2 | |
| 370 | 357M USD | 32 | 8 | 38 | 8 | 0 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score